Martin Paul Audycki, PT | |
1564 Long Pond Rd, Rochester, NY 14626-4119 | |
(585) 227-2580 | |
(585) 227-3077 |
Full Name | Martin Paul Audycki |
---|---|
Gender | Male |
Speciality | Physical Therapist |
Location | 1564 Long Pond Rd, Rochester, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023103959 | NPI | - | NPPES |
10363 | Other | NY | PT LICENSE NUMBER |
11225297 | Other | NY | CAQH ID NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 10363 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Martin Paul Audycki, PT 1564 Long Pond Rd, Rochester, NY 14626-4119 Ph: (585) 227-2580 | Martin Paul Audycki, PT 1564 Long Pond Rd, Rochester, NY 14626-4119 Ph: (585) 227-2580 |
News Archive
Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted orphan drug designation to the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the treatment of pancreatic cancer as well as stage IIB-IV melanoma.
Research presented today at Neuroscience 2009, the annual meeting of the Society for Neuroscience (SfN) and the world's largest source of emerging news about brain science and health, provides a better understanding of the brain, nervous system, and related disorders.
Wake Forest Baptist Medical Center has received a $3.8 million, five-year grant from the National Institute for Neurological Disorders and Stroke, part of the National Institutes of Health, to continue studying the effects of head impacts in youth league football.
Igenica Biotherapeutics, a company focused on the discovery and development of innovative antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer, announced today that the first patient has been dosed in a Phase 1 clinical trial of IGN523 in patients with relapsed or refractory acute myeloid leukemia (AML).
Bedside baths in the hospital are nothing new. They are typically done for patient comfort and to maintain basic personal hygiene.
› Verified 3 days ago
Carrie Marie Nicholas, Physical Therapist Medicare: Medicare Enrolled Practice Location: 3399 Winton Rd S, Rochester, NY 14623 Phone: 585-334-6000 | |
Hannah Steiner Becker, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Elmwood Ave, Suite 100, Rochester, NY 14620 Phone: 585-271-0761 | |
Jacob Resnick, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 515 Long Pond Rd, Rochester, NY 14612 Phone: 585-227-2310 Fax: 585-227-2312 | |
Laura Jean Mcgowan, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 620 Westfall Rd, Rochester, NY 14620 Phone: 585-461-8500 | |
Shelby Hutton, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Elmwood Ave Ste 400, Rochester, NY 14620 Phone: 585-271-0680 | |
Lattimore Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 383 White Spruce Blvd, Rochester, NY 14623 Phone: 585-442-6067 Fax: 585-442-6073 | |
Mrs. Shannon N Schiller, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 Erie Canal Dr, Suite 310, Rochester, NY 14626 Phone: 585-225-6296 Fax: 585-225-2839 |